C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2001
11/13/2001	US6316219 Compounds
11/13/2001	US6316217 Activin receptor-like kinases, proteins having serine threonine kinase domains and polynucleotides encoding same
11/13/2001	US6316208 Methods for determining isolated p27 protein levels and uses thereof
11/13/2001	US6316203 Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/13/2001	US6315995 Adding to blood inactive recombinant mutein comprising proteolytically inactive mutein of factor ix or ixa to inhibit clot formation, does not interfere with hemostasis when the blood is administered to a patient
11/13/2001	US6315988 Reacting dihydroxyphenylalanine or tyrosine with an oxidant enzyme in an acidic medium in the presence of a protein and/or peptide
11/10/2001	CA2347151A1 Method for screening a substance having promoting activity on hair growth
11/08/2001	WO2001083806A1 Immunoglobulin binding protein arrays in plant cells
11/08/2001	WO2001083805A2 Improved e. coli extract for protein synthesis
11/08/2001	WO2001083804A2 A method for improving recombinant protein stability and solubility
11/08/2001	WO2001083785A2 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083771A2 Human phospholipase c delta 5
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083749A2 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	WO2001083744A2 Natrium-calcium exchanger protein
11/08/2001	WO2001083718A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	WO2001083707A2 Chondrocyte cultures and anti-angiogenic fractions therefrom
11/08/2001	WO2001083701A2 Light-driven energy generation using proteorhodopsin
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083555A2 Pain signaling molecules
11/08/2001	WO2001083543A1 Human wingless-like gene
11/08/2001	WO2001083530A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	WO2001083527A2 Glucagon antagonists
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents
11/08/2001	WO2001083524A2 Rna metabolism proteins
11/08/2001	WO2001083516A1 Laminin 15 and uses thereof
11/08/2001	WO2001082944A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	WO2001082901A1 New antibodies to biological membranes
11/08/2001	WO2001038872A3 Assay of isomerised and/or optically inverted proteins
11/08/2001	WO2001038348A3 G-protein coupled receptor htogh35
11/08/2001	WO2001036630A3 Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells, and antibodies that identify the same
11/08/2001	WO2001036489A3 Erythropoietin forms with improved properties
11/08/2001	WO2001036485A3 Recombinant monoclonal antibodies recognizing antigen ior c2 and the use thereof in the diagnosis and treatment of colorectal tumors
11/08/2001	WO2001032614A3 Novel genes tzap7/a, tzap7/b and tzap7 involved in t cell activation and uses thereof
11/08/2001	WO2001032128A3 Human chemokine beta-13
11/08/2001	WO2001023414A3 Immunologically significant herpes simplex virus antigens
11/08/2001	WO2000006713A8 Methods for recombinant protein production in mammalian cells comprising co-expression with fetuin
11/08/2001	US20010039479 Three-dimensional model of a Fc region of an IgE antibody and uses thereof
11/08/2001	US20010039332 Monoclonal antibodies to 4,4'-dinitrocarbanilide and a method for analyzing for the drug nicarbazin
11/08/2001	US20010039027 Cyclitol containing carbohydrates from human tissue which regulate lipogenic activity
11/08/2001	US20010039008 Immunofluorescence
11/08/2001	US20010038843 Immunogenic polypeptide comprising a self Immunoglobin E (IgE) portion and a non-self IgE portion, to induce an anti-self IgE response in a mammal; treating diseases such as allergies
11/08/2001	CA2750984A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2414775A1 A method and device for improving protein stability and solubility
11/08/2001	CA2407965A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	CA2407959A1 Human wingless-like gene
11/08/2001	CA2407956A1 Modified peptides as therapeutic agents
11/08/2001	CA2407887A1 Natrium-calcium exchanger protein
11/08/2001	CA2407746A1 Proteases
11/08/2001	CA2407709A1 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	CA2407603A1 Porphyromonas gingivalis recombinant proteins and truncations
11/08/2001	CA2407601A1 Novel human phospholipase c delta 5
11/08/2001	CA2407595A1 Mutant strains capable of producing chemically diversified proteins by incorporation of non-conventional amino acids
11/08/2001	CA2407435A1 Rna metabolism proteins
11/08/2001	CA2407219A1 Pain signaling molecules
11/08/2001	CA2406999A1 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners
11/08/2001	CA2406746A1 Methods and compositions for impairing multiplication of hiv-1
11/08/2001	CA2400755A1 Improved e. coli extract for protein synthesis
11/08/2001	CA2377877A1 Immunoglobulin bonding protein arrays in plant cells
11/07/2001	EP1151304A2 METHOD OF IDENTIFYING N-TERMINAL proBNP
11/07/2001	EP1151299A1 Method of site specific labeling of proteins and uses therefor
11/07/2001	EP1151143A1 Selection of proteins using rna-protein fusions
11/07/2001	EP1151131A1 Process for the preparation of pseudomonic acid a antibiotic by microbiological method
11/07/2001	EP1151117A1 Intein-mediated protein ligation of expressed proteins
11/07/2001	EP1151112A1 Heat-inducible promoter
11/07/2001	EP1151109A1 Fucosyl transferase gene
11/07/2001	EP1151108A1 The ltr region of msrv-1 and the proteins it encodes, and probes and methods for detecting msrv-1 retrovirus
11/07/2001	EP1151107A1 Basb059 polypeptides from neisseria meningitidis
11/07/2001	EP1151106A2 Methods for producing polypeptides in fungal cells
11/07/2001	EP1151102A1 Glycosylated leptin compositions and related methods
11/07/2001	EP1151101A1 Prostacyclin-stimulating factor-2
11/07/2001	EP1151095A1 Polypeptide variants with raised heparin-binding capacity
11/07/2001	EP1151012A1 Rhamm antagonist antibodies
11/07/2001	EP1151011A1 Anti-ccr1 antibodies and methods of use therefor
11/07/2001	EP1151002A1 Antibodies specific to kdr and uses thereof
11/07/2001	EP1150994A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
11/07/2001	EP0912901B1 Method and reagent for monitoring blood levels of antiplatelet compounds
11/07/2001	CN1321195A Peptidyl prolyl cis-trans isomerases
11/07/2001	CN1321190A i(Ehrlichia canis) 120-KDa immunodominant antigenic protein and gene
11/07/2001	CN1321165A Prevention and treatment of viral disease
11/07/2001	CN1321064A Plant resistance to insect pests medicated by viral proteins
11/07/2001	CN1074458C Human monoclonal antibodies specific to cell cycle independent glioma surface antigen
11/07/2001	CN1074422C Method for preparing HCV epitope-contg. separated polypeptide
11/06/2001	US6313378 Transgenic plant for use in biological pest control
11/06/2001	US6313281 Nucleic acid encoding OMP26 antigen from Haemophilus influenzae
11/06/2001	US6313276 Human endothelin receptor
11/06/2001	US6313269 Tumor necrosis factor related receptor, TR6
11/06/2001	US6313264 Effector proteins of Rapamycin
11/06/2001	US6313263 γ, δ T cell receptor and methods for detection
11/06/2001	US6312951 Expression augmenting sequence elements (ease) for eukaryotic expression systems
11/06/2001	US6312922 Complementary DNAs
11/06/2001	US6312921 Nucleotide sequences which code preferential polyeptides; for use in diagnosis and treatment of tumors
11/06/2001	US6312916 Mutant polypeptide; for use in reduction of inteference associated with immunoassays
11/06/2001	US6312907 An isolated nucleic acid encoding a gene for decorin binding protein from borrelia; diagnosis and therapy of lyme disease in humans and animals
11/06/2001	US6312899 A polynucleotide probe for the detection and diagnositic staging of lymphocyte differentiation
11/06/2001	US6312890 Partial intron sequence of von hippel-lindau (VHL) disease gene and its use in diagnosis of disease
11/06/2001	US6312699 Genetic engineering of adenoviral fiber protein with caboxy end group
11/06/2001	US6312694 Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids

1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 1125